Department of Experimental and Clinical Pharmacology
Where Bench and Patient-Centered Research Come Together
The Department of Experimental and Clinical Pharmacology (ECP) is at the forefront of the emerging discipline of experimental pharmacotherapeutics, providing national and international leadership in individualized medicine through prominent research and an excellent graduate program.
This cross-disciplinary paradigm translates basic scientific discoveries into safe and effective therapeutic uses by providers and patients, through laboratory experiments and clinical studies. Clinical data can also prompt new questions and investigations, leading back to the bench and beginning a new cycle of translational research.
Prepare for your career in clinical research with a PhD or M.S. Degree in Experimental and Clinical Pharmacology. The program is designed for students interested in clinical and translational research and advancing the science of human pharmacology and therapeutics to improve the safe, effective and economical use of drugs by patients.
Elizabeth Hirsch Making an Early Impact
Dr. Elizabeth Hirsch joined ECP in July 2017. In her first year with our faculty, she has had a significant impact on research, teaching, and service in the department. Dr. Hirsch has two sponsored studies ongoing: "Activity of Ceftolozane/Tazobactam (C/T) and Ceftazidime/Avibactam (CZA) against Multidrug-Resistant Clinical Isolates" and "A Retrospective Multi-Center Study to Assess Patient Outcomes Following Treatment with Ceftolozane/Tazobactam," along with multiple other projects.
Dr. Hirsch mentors undergraduate UROP awardee Jadyn Anderson and research-emphasis PD3 students Melanie Mahoney and Elizabeth Smith. Elizabeth was recently awarded a summer Melendy scholarship for her project, "Characterizing the Activity of Fosfomycin against Pseudomonas aeruginosa and Identifying Contemporary Bacterial Resistance Mechanisms". Dr. Hirsch's Full Bio